Key Details
Annual ROE
86.84%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Feb 08, 2023Recent annual earnings:
June 24, 2022Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 03, 2022Analyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with QTNT included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Quotient Limited doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Quotient Limited?
- What is the ticker symbol for Quotient Limited?
- Does Quotient Limited pay dividends?
- What sector is Quotient Limited in?
- What industry is Quotient Limited in?
- What country is Quotient Limited based in?
- When did Quotient Limited go public?
- Is Quotient Limited in the S&P 500?
- Is Quotient Limited in the NASDAQ 100?
- Is Quotient Limited in the Dow Jones?
- When was Quotient Limited's last earnings report?
- When does Quotient Limited report earnings?
What is the primary business of Quotient Limited?
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, commercializes, and sells products for the global transfusion diagnostics market in the United States, France, Japan, and internationally. The company is developing MosaiQ, a proprietary technology platform, which provides tests for immunohematology, serological disease screening, and molecular disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood group antigens; reagent red blood cells, which enable the identification of blood group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. The company also offers MosaiQ COVID-19 Microarray that is designed as a serological disease screening microarray specific to COVID-19 antibody detection. It sells its products to hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operation and other diagnostics companies. Quotient Limited was founded in 2007 and is headquartered in Eysins, Switzerland.
What is the ticker symbol for Quotient Limited?
The ticker symbol for Quotient Limited is NASDAQ:QTNT
Does Quotient Limited pay dividends?
No, Quotient Limited does not pay dividends
What sector is Quotient Limited in?
Quotient Limited is in the Healthcare sector
What industry is Quotient Limited in?
Quotient Limited is in the Diagnostics & Research industry
What country is Quotient Limited based in?
Quotient Limited is headquartered in Switzerland
When did Quotient Limited go public?
Quotient Limited's initial public offering (IPO) was on 16 April 2014
Is Quotient Limited in the S&P 500?
No, Quotient Limited is not included in the S&P 500 index
Is Quotient Limited in the NASDAQ 100?
No, Quotient Limited is not included in the NASDAQ 100 index
Is Quotient Limited in the Dow Jones?
No, Quotient Limited is not included in the Dow Jones index
When was Quotient Limited's last earnings report?
Quotient Limited's most recent earnings report was on 8 February 2023
When does Quotient Limited report earnings?
The date for Quotient Limited's next earnings report has not been announced yet